Source:http://linkedlifedata.com/resource/pubmed/id/11254466
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2001-3-20
|
pubmed:abstractText |
Overt nephrotic syndrome is characterized by albumin and fibrinogen hyperproduction and reduced very low density lipoprotein apolipoprotein B-100 (VLDL apoB-100) clearance. Whether similar changes also occur in low-grade proteinuria is not known. Thus we measured albumin, fibrinogen, and VLDL apoB-100 kinetics in six patients with modest proteinuria and normal creatinine clearance (P) and in ten control subjects (C) by leucine tracer infusion and precursor-product relationships. In P, plasma albumin concentration was decreased (P < 0.003), whereas concentrations of fibrinogen and VLDL apoB-100 were increased (P < 0.001). In P, albumin fractional secretion rate (FSR) was increased (P < 0.01), fibrinogen FSR was normal, and VLDL apoB-100 FSR was decreased (P < 0.03). As a result, in P, absolute secretion rates (ASR) of albumin and fibrinogen were increased (P < 0.03), whereas VLDL apoB-100 ASR was normal. Albumin FSR was inversely correlated to oncotic pressure in P but not in C. These findings suggest that low-grade nephrotic proteinuria is characterized by simultaneous multiple alterations in turnover rates of albumin, fibrinogen, and VLDL apoB-100. Their pathogenesis, however, appears to be multifactorial.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Apolipoprotein B-100,
http://linkedlifedata.com/resource/pubmed/chemical/Apolipoproteins B,
http://linkedlifedata.com/resource/pubmed/chemical/Blood Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Fibrinogen,
http://linkedlifedata.com/resource/pubmed/chemical/Lipoproteins, VLDL,
http://linkedlifedata.com/resource/pubmed/chemical/Serum Albumin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0193-1849
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
280
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
E591-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11254466-Adult,
pubmed-meshheading:11254466-Apolipoprotein B-100,
pubmed-meshheading:11254466-Apolipoproteins B,
pubmed-meshheading:11254466-Blood Proteins,
pubmed-meshheading:11254466-Female,
pubmed-meshheading:11254466-Fibrinogen,
pubmed-meshheading:11254466-Humans,
pubmed-meshheading:11254466-Kinetics,
pubmed-meshheading:11254466-Lipoproteins, VLDL,
pubmed-meshheading:11254466-Male,
pubmed-meshheading:11254466-Middle Aged,
pubmed-meshheading:11254466-Nephrotic Syndrome,
pubmed-meshheading:11254466-Proteinuria,
pubmed-meshheading:11254466-Serum Albumin
|
pubmed:year |
2001
|
pubmed:articleTitle |
Plasma protein synthesis in patients with low-grade nephrotic proteinuria.
|
pubmed:affiliation |
Departments of Metabolic Diseases and Internal Medicine, University of Padova, 35128 Padua, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|